A single-center, randomized, double-blind crossover study to evaluate the abuse potential, pharmacokinetics, and safety of milled and intranasally administered extended-release hydrocodone (HYD) in recreational opioid users

被引：0
|
作者：
Harris, S. [1 ]
Colucci, S. [1 ]
Perrino, P. [1 ]
Kapil, R. [1 ]
Hopyan, T. [1 ]
Levy-Cooperman, N. [1 ]
Geoffroy, P. [1 ]
机构：
[1] Purdue Pharma, Stamford, CT USA
来源：
JOURNAL OF PAIN | 2014年 / 15卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
441
引用
收藏
页码：S86 / S86
页数：1
相关论文
共 50 条
  • [41] Subjective Effects and Safety of Whole and Tampered Morphine Sulfate and Naltrexone Hydrochloride (ALO-01) Extended-Release Capsules versus Morphine Solution and Placebo in Experienced Non-Dependent Opioid UsersA Randomized, Double-Blind, Placebo-Controlled, Crossover Study
    Joseph Stauffer
    Beatrice Setnik
    Marta Sokolowska
    Myroslava Romach
    Franklin Johnson
    Edward Sellers
    Clinical Drug Investigation, 2009, 29 : 777 - 790
  • [42] A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of the Extended-Release Tramadol Hydrochloride/Acetaminophen Fixed-Dose Combination Tablet for the Treatment of Chronic Low Back Pain
    Lee, Jae Hyup
    Lee, Chong-Suh
    CLINICAL THERAPEUTICS, 2013, 35 (11) : 1830 - 1840
  • [43] A RANDOMIZED, SINGLE-CENTER, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTIPLE-DOSE, PHASE 1 STUDY TO EVALUATE THE SAFETY, PHARMACOKINETICS (PK), AND PHARMACODYNAMICS (PD) OF TAK-272 IN HEALTHY ADULT NON-ELDERLY AND ELDERLY MALE SUBJECTS
    Matsuno, K.
    Tanaka, S.
    Hashimoto, T.
    Nakamichi, H.
    Komura, E.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2017, 32 : 265 - +
  • [44] A Randomized, Double-Blind, Placebo Controlled, Single Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Lucid-21-302 in Healthy Volunteers (NCT05821387): A potential candidate targeting demyelination
    Chruscinski, Andrzej
    Speed, Joanne
    Ryk, Justin
    Joshi, Ashwini
    Kotra, Lakshmi
    MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 1074 - 1075
  • [45] A Phase 2a randomized, single-center, double-blind, placebo-controlled study to evaluate the safety and preliminary efficacy of oral iOWH032 against cholera diarrhea in a controlled human infection model
    Erdem, Rahsan
    Ambler, Gwen
    Al-Ibrahim, Mohamed
    Fraczek, Katarzyna
    Dong, Steven D.
    Gast, Christopher
    Mercer, Laina D.
    Raine, Michael
    Tennant, Sharon M.
    Chen, Wilbur H.
    de Hostos, Eugenio L.
    Choy, Robert K. M.
    PLOS NEGLECTED TROPICAL DISEASES, 2021, 15 (11):
  • [46] Pharmacokinetic-Pharmacodynamic Interaction Between Nebicapone and Controlled-Release Levodopa/Benserazide: A Single-Center, Phase I, Double-Blind, Randomized, Placebo-Controlled, Four-Way Crossover Study in Healthy Subjects
    Nunes, Teresa
    Machado, Rita
    Rocha, Jose F.
    Fernandes-Lopes, Carlos
    Costa, Raquel
    Torrao, Leonel
    Loureiro, Ana I.
    Falcao, Amuilcar
    Vaz-da-Silva, Manuel
    Wright, Lyndon
    Almeida, Luis
    Soares-da-Silva, Patricio
    CLINICAL THERAPEUTICS, 2009, 31 (10) : 2258 - 2271
  • [47] Long-term efficacy and safety of Zolpidem extended-release 12,5 mg, administered for six months in old patients with chronic primary insomnia: A randomized, double-blind, placebo-controlled, parallel-group, multicenter study
    Zarra, Julio
    Schmidt, L.
    INTERNATIONAL PSYCHOGERIATRICS, 2011, 23 : S387 - S388
  • [48] A SINGLE-CENTER, FIRST-IN-HUMAN, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP STUDY TO INVESTIGATE THE SAFETY, TOLERABILITY AND PHARMACOKINETICS OF ESCALATING SINGLE DOSES OF EMODEPSIDE (BAY44-4400) IN HEALTHY MALE SUBJECTS
    Gillon, Jean
    van den Berg, Frans
    Cheeseman, Karen
    Hopchet, Nathalie
    Delhomme, Sophie
    Rossi, Claudia
    Monnot, Frederic
    Strub-Wourgaft, Nathalie
    Rodriguez, Maria-Luisa
    Don, Rob
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2018, 99 (04): : 168 - 168
  • [49] A single-center, double-blind, randomized, placebo-controlled, two-arm study to evaluate the safety and efficacy of once-weekly sirolimus (rapamycin) on muscle strength and endurance in older adults following a 13-week exercise program
    Stanfield, Brad
    Kaeberlein, Matt
    Leroux, Brian
    Jones, Julie
    Lucas, Ruth
    Arroll, Bruce
    TRIALS, 2024, 25 (01)
  • [50] Long-term efficacy and safety of zolpidem extended-release 12.5 mg, administered 3 to 7 nights per week for 24 weeks, in patients with chronic primary insomnia: A 6-month, randomized, double-blind, placebo-controlled, parallel-group, multicenter study
    Krystal, Andrew D.
    Erman, Milton
    Zammit, Gary K.
    Soubrane, C.
    Roth, Thomas
    SLEEP, 2008, 31 (01) : 79 - 90
12345